Few companies in the biotech industry have performed better in the past two years than Summit Therapeutics ( SMMT -2.71%). The drugmaker's shares are up by nearly 540%, thanks to excellent clinical ...
Bio-Techne (NASDAQ:TECH – Get Free Report) had its target price increased by research analysts at Royal Bank of Canada from $79.00 to $80.00 in a research note issued on Thursday,Benzinga reports. The ...
The maker of Yankee Candle and Sharpie pens said volumes fell and foreign exchange rates were a headwind in the fourth quarter. The sports-car maker warned that profits will be hurt this year as it ...